Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT01990053 |
Other study ID # |
2013B0307 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
April 14, 2014 |
Est. completion date |
May 1, 2017 |
Study information
Verified date |
March 2023 |
Source |
Ohio State University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Standard treatments for depression in specialty care settings are effective but resources for
delivering empirically supported psychotherapies are often limited. Computerized cognitive
behavioral therapy (cCBT) is an effective and highly scalable treatment for depression that
might help expand services in psychiatric settings, however, little is known about its
efficacy in this population. The present study aims to establish the efficacy of a
internet-delivered cCBT program ("Beating the Blues") plus email and telephone support for
depression in a psychiatric outpatient clinic setting. The secondary aim is to pilot an
assessment procedure designed to identify moderators of treatment effectiveness.
Description:
Currently, outpatient psychiatric settings are plagued by long wait times and are often
unable to accommodate all individuals seeking services. Furthermore, a lack of trained
therapists in these settings means that many treatment seekers do not have access to
empirically supported psychotherapeutic treatments such as cognitive behavioral therapy.
"Beating the Blues" (BtB) is a computerized, internet-delivered, cognitive behavioral
treatment for depression. BtB is highly scalable and might enable a larger proportion of
individuals to receive cognitive behavioral therapy in a psychiatric setting while also
reducing therapist time. Although computerized CBT interventions have proven effective in
primary care settings, there is no research demonstrating the effectiveness of cCBT in
secondary care settings in the United States. Thus the primary goal of the proposed research
is to test the efficacy of BtB in a specialty care sample.
Patients presenting to these settings tend to have more severe and complex psychopathology
than those presenting to primary care. Although BtB is likely effective, computerized
treatments do carry a higher risk of dropout and non-response. Therefore, reliable and valid
predictors of response are needed to determine who is most likely to respond to the
treatment, versus who is likely to fail or drop out. Thus the second aim of the current
proposal is to pilot an assessment procedure containing a number of potential predictors of
cCBT response and investigate these predictors for inclusion in a larger validation study.
The current trial is a pilot study with a randomized waitlist control design with optional
delayed treatment for individuals randomized to the waitlist condition. For the first phase,
the investigators will enroll 90 treatment-seeking adults 18 or older recruited from a pool
of individuals seeking outpatient psychiatric services at a hospital clinic. Sixty (n=60)
individuals will be assigned immediate treatment group with BtB plus telephone and email
support, and n=30 to the waitlist/delayed BtB plus telephone and email support group.
Efficacy will be assessed over 8 weeks using the Hamilton Rating Scale for Depression (pre to
post treatment) and the PHQ9 (measured at weeks 1-8). There will also be a 1-year follow-up
survey with biweekly symptom assessments throughout the year for treatment responders (weeks
9-61). Potential predictors of outcome include demographics, CBT skills, personality
measures, cognitive functioning, measures of attitudes and beliefs, social functioning,
psychiatric comorbidity and depression illness characteristics, and psychophysiological
measures. A second phase will enroll sixty individuals (n=60), who will be assigned immediate
treatment group in order to validate the predictive model constructed during Phase 1.